NCT05263531

Brief Summary

The most recent treatment for stroke rehabilitation is to combine physical training with other therapies to enhance or accelerate recovery.The hypothesis of this study is that remote ischemic conditioning (RIC) might have a beneficial effect on motor recovery of AIS

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

December 31, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

March 2, 2022

Status Verified

August 1, 2021

Enrollment Period

1 year

First QC Date

December 1, 2020

Last Update Submit

February 27, 2022

Conditions

Keywords

remote ischemic conditioning

Outcome Measures

Primary Outcomes (1)

  • changes in Fugl-Meyer score

    Fugl-Meyer scale assessment (FMA) will be used for assessing improvement of motor function. Total score of FMA range from 0 to 100, a score of 100 means full recovery of motor function

    0-3 months

Secondary Outcomes (2)

  • Changes of the level of angiogenesis related factors

    0-3 months

  • changes in Barthel Index

    0-3months

Study Arms (2)

remote ischemic conditioning

EXPERIMENTAL

Receiving remote ischemic conditioning (RIC) treatment with pressure set at 200 mmHg.

Device: remote ischemic conditioning

placebo remote ischemic conditioning

SHAM COMPARATOR

Receiving sham RIPC treatment with pressure set at 60 mmHg

Device: remote ischemic conditioning

Interventions

RIC is a physical strategy performed by an electric autocontrol device with cuffs placed on bilateral arms and inflated to design pressure for 5-min followed by deflation for 5-min, the procedures is performed repeatedly for 5 times.

placebo remote ischemic conditioningremote ischemic conditioning

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged 18-80 years;
  • First-ever unilateral ischemic stroke,5\~10 days after onset;
  • Had motor dysfunction caused by stroke(Fugl-Meyer≤55)
  • mRS≤1 before stroke
  • NIHSS 6\~20
  • Written consent was obtained from the subject.

You may not qualify if:

  • Cannot complete assessments-ie, psychiatric disorders, sensory aphasia, dementia
  • brainstem lesion or cerebellun lesion
  • poorly controlled diabetes mellitus
  • Application of agent which thought to impair or improve recovery based on laboratory and clinical evidence within 1 month (ie,DA,MAOI, SSRI,α1/α2 adrenergic receptor inhibitors,BZD,etc)
  • severe soft tissue injury, fracture, or peripheral vascular disease in the upper limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuan Wu Hospital,Capital Medical University

Beijing, Beijing Municipality, 100053, China

RECRUITING

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Xunming Ji, MD PhD

    Capital Medical University Xuan Wu Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Neurosurgery, Vice-President of Xuan Wu Hospital, Capital Medical University

Study Record Dates

First Submitted

December 1, 2020

First Posted

March 2, 2022

Study Start

December 31, 2021

Primary Completion

December 31, 2022

Study Completion

January 31, 2023

Last Updated

March 2, 2022

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will share

Locations